Hypertension and Urine Protease Activity in Preeclampsia
NCT01828138 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2015-10-16
Summary
Preeclampsia (PE) is a common disorder of pregnancy that complicates 4-7% of all pregnancies. It is a serious condition with acute proteinuria and hypertension and varying degrees of edema after 20 weeks of gestation. PE leads to a severe risk of low birth weight because of prematurity with inherent complications. The pathogenesis is unknown but is assumed to involve placental ischemia.The primary placental disorder results in renal glomerular injury. Established PE is associated with paradoxical suppression of the renin-angiotensin-aldosterone system, RAAS.
Despite suppressed RAAS, patients with PE retain NaCl(sodium chloride) after an intravenous isotonic NaCl overload compared to healthy pregnant women on a low NaCl diet. The investigators believe to have data that provide a possible explanation for the overall relationship between proteinuria, NaCl retension, suppression of RAAS, hypertension and underdevelopment of placenta. Earlier data, which the investigators have confirmed, shows abnormal glomerular loss of the enzyme plasmin/plasminogen from plasma to the urine in PE. Active plasmin in urine from patients with nephrotic syndrome and PE activates the epithelial sodium channel ( ENaC ) in renal collecting duct cells. The investigators hypothesize that loss of plasmin/plasminogen are shared for the diseases with proteinuria, including PE, and that plasmin- driven ENaC (epithelial sodium channel) activation is a causal factor in the pathophysiology of established PE. Hyperactive ENaC causes primary renal sodium retention with secondary suppression of the renin-angiotensin-aldosterone system. Aldosterone is recently established as a placental growth factor.
Plasma-aldosterone levels are significant higher in normal pregnant women. PE is characterized by low aldosterone levels (a discovery the investigators have also confirmed) and by placental underdevelopment.
Study Aim: To test specific hypothesis regarding established PE´s pathophysiological mechanisms.
Study Hypothesis:
1. Excretion of urine proteases (plasmin/plasminogen) in PE leads to an activation of ENaC and hence RAAS is less NaCl sensitive while the blood pressure is more NaCl sensitive compared to healthy pregnant women.
2. The degree of aldosterone suppression in PE determines placental development
Conditions
- Preeclampsia
- Hypertension
- Proteinuria
- Pregnancy
Interventions
- DIETARY_SUPPLEMENT
-
Sodium
supplemental sodium tablets 150-200 mmol/day in 5 days
- DIETARY_SUPPLEMENT
-
Placebo
Placebo are given in 5 days
Sponsors & Collaborators
-
The Danish Council for Strategic Research
collaborator OTHER -
Lundbeck Foundation
collaborator OTHER -
Odense University Hospital
lead OTHER
Principal Investigators
-
Boye L. Jensen, Professor · cardiovascular and renal research department, Odense University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- Denmark
Study Locations
More Related Trials
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NCT05056701 ·Status: RECRUITING ·Phase: NA
-
Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring
NCT04823949 ·Status: COMPLETED ·Phase: NA
-
Preeclampsia and Contact Activation
NCT04825145 ·Status: COMPLETED
-
Detection and Identification of Preeclampsia Via Volatile Biomarkers
NCT01291342 ·Status: COMPLETED
-
Kidney Injury Biomarkers in Preeclampsia
NCT03217916 ·Status: UNKNOWN
-
Serum Markers in Preeclamptic Women
NCT01361737 ·Status: COMPLETED
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Mild Preeclampsia Near Term: Deliver or Deliberate?
NCT00789919 ·Status: COMPLETED ·Phase: NA
-
ToRsemide for pOstpartum HYpertension
NCT02813551 ·Status: COMPLETED ·Phase: PHASE2
-
Association Between Pococyturia and Pre-eclampsia Severity
NCT03316391 ·Status: COMPLETED
-
Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
NCT02221830 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049 ·Status: UNKNOWN
-
Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study
NCT07185204 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acid-Base and Point of Care Ultrasound in Severe Preeclampsia
NCT02721771 ·Status: COMPLETED
-
Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia
NCT01095939 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Suspected Preeclampsia Based on 6-hour Versus 24-hour Urine Protein Collection
NCT03724786 ·Status: UNKNOWN ·Phase: NA
-
Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia
NCT00870428 ·Status: UNKNOWN
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
NCT02333240 ·Status: COMPLETED ·Phase: NA
-
Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe Features
NCT05152550 ·Status: UNKNOWN
-
Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive Disorders
NCT01508208 ·Status: COMPLETED ·Phase: NA
-
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
NCT00533871 ·Status: COMPLETED
-
Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)
NCT02801695 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Random Urine Protein-creatinin Ratio to Predict Magnitude of Proteinuria
NCT01623791 ·Status: UNKNOWN